- A$5m placement with the ability to accept overs.
- Placement Price: A$0.42 per share.
- Discount to last close of A$0.50/sh: 16.0%.
- Discount to 5 trading day VWAP of A$0.512/sh: 17.9%.
- Discount to 10 trading day VWAP of A$0.505/sh: 16.9%.
Artrya Limited (ASX:AYA)
AYA
Lead Manager
Offer Price
A$0.420
per share
Offer Size
A$5,000,000
Key Offer Details
Issue Price (Per Share)
A$0.420
Discount
13.40%
Offer Size
A$5,000,000
Shares Available
11,904,761
Use of Funds
Funds raised will be applied to product development, clinical, research and development, regulatory works, IT infrastructure & security and offer costs.
- Product Development: $3.0M
- Clinical, R&D & Regulatory: $1.5M
- Working Capital, IT and offer costs: $0.5M
Indicative Timetable
The company reserves the right to change any date on the timetable.
Please note times are in ADST.
Offer Open
8 November 2024
Offer Closed
4pm, 8 November 2024
Placement Settlement Date
18 November 2024
Placement Allotment Date
19 November 2024
Documents & Downloads
Disclaimer
This site does not constitute an offer, recommendation, or invitation to any person, nor does it purport to provide all of the information an interested party may require in order to investigate the affairs of Artrya Limited. This site is provided for information only and has not been prepared with the intention that the recipient should rely on it. Liquidity Technology Pty Ltd ("Liquidity") does not make any representation in relation to the contents of this site or give any assurances as to the accuracy or the degree of care or diligence used in preparing this document. The information, data, and advice herein is provided to recipients on the clear understanding that Liquidity nor any of its representatives, directors, officers, employees, agents, or advisers makes any representation or warranty about its accuracy, reliability, completeness, or suitability for any particular purpose and does not accept liability (including, but not limited to, for any expenses, losses, damages, and/or costs (including, but not limited to, indirect or consequential damage)) nor take any responsibility of any kind whatsoever (including, but not limited to, whether in contract, tort, financial or otherwise) for the information, data, or advice contained in or for any omission or for any other information, statement, or representation provided to any recipient (including, but not limited to, as a result of information, data, or advice being inaccurate, unreliable, incomplete, or unsuitable in any way and for any reason whatsoever). Users of this site must conduct their own investigation and analysis regarding any information, statement, or representation contained or provided to any recipient or its associates by Liquidity or any of the Liquidity Personnel. Each recipient waives any right of action, which it has now or in the future against Liquidity or any of the Liquidity Personnel in respect of any errors or omissions on or from this site, however caused. All rights are reserved. If the whole or any part of a provision of this "Notice and Disclaimer" is invalid, illegal, or unenforceable, then such provision will be severed and neither that part or provision or its severance will affect the validity or enforceability of the remaining parts or provisions.
Disclosure of Interest: Liquidity receives commission from dealing in securities and its introducers of business may directly share in this commission. Liquidity and its associates may hold shares in Artrya Limited.